Nur Nicholson - 13 Mar 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Nur Nicholson
Issuer symbol
APLS
Transactions as of
13 Mar 2024
Net transactions value
-$645,838
Form type
4
Filing time
14 Mar 2024, 16:17:21 UTC
Previous filing
31 Jan 2024
Next filing
14 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $445,161 -7,768 -12% $57.31 59,739 13 Mar 2024 Direct F1
transaction APLS Common Stock Sale $200,677 -3,452 -5.8% $58.13 56,287 13 Mar 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $56.91 - $57.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $57.92 - $58.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.